Congress, Controlled Substances, and Physician-Assisted Suicide — Elephants in Mouseholes
- 9 March 2006
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (10), 1079-1084
- https://doi.org/10.1056/nejmlim060731
Abstract
The U.S. Supreme Court's decision in Gonzales v. Oregon to reject the U.S. attorney general's authority to prohibit physicians in Oregon from prescribing Schedule II drugs for their terminally ill patients to commit suicide can seem paradoxical and confusing.1 How is it that California cannot permit the patients of physicians who recommend marijuana, a Schedule I drug, to possess legally and use marijuana that they may need to survive, but Oregon can legally permit physicians to prescribe Schedule II drugs and patients to possess and use such drugs to end their lives?Keywords
This publication has 7 references indexed in Scilit:
- The 100 000 Lives CampaignJAMA, 2006
- The Big Chill — Inserting the DEA into End-of-Life CareNew England Journal of Medicine, 2006
- The American Public and the Terri Schiavo CaseArchives of Internal Medicine, 2005
- Jumping Frogs, Endangered Toads, and California's Medical-Marijuana LawNew England Journal of Medicine, 2005
- “Culture of Life” Politics at the Bedside — The Case of Terri SchiavoNew England Journal of Medicine, 2005
- The Social, Professional, and Legal Framework for the Problem of Pain Management in Emergency MedicinePublished by Cambridge University Press (CUP) ,2005
- Death by PrescriptionNew England Journal of Medicine, 1994